Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.
We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.
We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon.
Obesity Doctor: Topamax? Ozempic? BEST Rx For Weight Loss? Rapid Weight Loss Pills
Location
Lisbon
Publication date
Reference
News release
In United States Publish Post Time: 2025-07-19
Hello friends,
There are many medications now that are FDA approved for weight loss -- what are they and how well do they work? Let's go through the data!
References:
Bays H, McCarthy W, Burridge K, Tondt J, Karjoo S, Christensen S, Ng J, Golden A, Davisson L, Richardson L. Obesity Algorithm, presented by the Obesity Medicine Association 2021.
WT Garvey et al. Step 5 Study Group. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022 Oct;28(10):2083-2091. PMID: 36216945
BT Grover et al. Defining Weight Loss After Bariatric Surgery: a Call for Standardization. Obes Surg. 2019 Nov;29(11):3493-3499. PMID: 31256357
AM Jastreboff et al. SURMOUNT 1 Trial. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med 2022; 387:205-216. PMID: 35658024
X Pi-Sunyer et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015. Jul 2;373(1):11-22. PMID: 26132939
DM Rubino et al. Step 8 Investigators. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022 Jan 11;327(2):138-150. PMID: 35015037
JPH Wilding et al. STEP 1 Trial. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18;384(11):989-1002. PMID: 33567185
Obesity Doctor: Topamax? Ozempic? BEST Rx For Weight Loss? For Country: United States. City: Coral Springs, Elk Grove, Escondido, Fairfield, Nashville
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:
Kathy Robertson
Principal manager
Media relations and corporate communication